Weitgasser Raimund, Ratzinger Michaela, Hemetsberger Margit, Siostrzonek Peter
Abteilung für Innere Medizin/Kompetenzzentrum Diabetes, Privatklinik Wehrle-Diakonissen Salzburg, Salzburg, Österreich.
Paracelsus Medizinische Privatuniversität Salzburg, Salzburg, Österreich.
Wien Med Wochenschr. 2018 Apr;168(5-6):108-120. doi: 10.1007/s10354-016-0518-2. Epub 2016 Oct 21.
For over 30 years, intensive research efforts investigated the role of LDL cholesterol in the pathogenesis of cardiovascular disease. In various settings, large statin trials showed an association between LDL cholesterol levels and cardiovascular event rates. This association is often referred to as the 'LDL cholesterol hypothesis'. More recent trials on agents with totally different modes of action confirmed this association and indicated a causal relationship between lower LDL cholesterol levels and improved cardiovascular outcomes. It has been proposed to term this causal relationship the 'LDL cholesterol principle'. It is to be expected that currently ongoing outcomes trials will further support the assumption of a causal relationship and will finally offer an armamentarium to therapists that will enable individualized treatment of dyslipidemias and their sequelae.
30多年来,大量研究致力于探究低密度脂蛋白胆固醇在心血管疾病发病机制中的作用。在各种情况下,大型他汀类药物试验表明低密度脂蛋白胆固醇水平与心血管事件发生率之间存在关联。这种关联通常被称为“低密度脂蛋白胆固醇假说”。最近针对具有完全不同作用方式的药物进行的试验证实了这种关联,并表明较低的低密度脂蛋白胆固醇水平与改善心血管结局之间存在因果关系。有人提议将这种因果关系称为“低密度脂蛋白胆固醇原则”。可以预期,目前正在进行的结局试验将进一步支持因果关系的假设,并最终为治疗师提供一系列手段,从而能够对血脂异常及其后遗症进行个体化治疗。